A predominance of Th17 cells and deficient or defective T regulatory cells have been reported in SLE (29, 30), and GILZ has been shown to both regulate the proliferation of Th17 cells (31), and favor T regulatory cell differentiation (32). This evidence concerns the gene TSC22D3 and systemic lupus erythematosus.